Erythropoietin: a new perspective in cardiovascular therapy
Erythropoietin is a hormone produced by the kidney, which regulates proliferation, differentiation and maturation of red cells. Recombinant human EPO (rH-EPO) is well known to correct anaemia in patients with chronic renal failure in terminal stage. However, recent studies showed the existence of se...
Main Authors: | Riccardo Raddino, Debora Robba, Giorgio Caretta, Ivano Bonadei, Melissa Teli, Gregoriana Zanini, Alberto Madureri, Enrico Vizzardi, Livio Dei Cas |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2016-01-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/414 |
Similar Items
-
Peripartum Cardiomyopathy
by: Riccardo Raddino, et al.
Published: (2016-01-01) -
Diagnostic value of the head-up tilt test and the R-test in patients with syncope
by: Debora Robba, et al.
Published: (2006-12-01) -
APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01) -
"EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY"
by: A. Mohammadzadeh, et al.
Published: (2005-04-01) -
"EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY"
by: A. Mohammadzadeh, et al.
Published: (2005-05-01)